Subcutaneous Methadone in Terminally Ill Patients
- 1 July 1999
- journal article
- research article
- Published by Elsevier in Journal of Pain and Symptom Management
- Vol. 18 (1) , 49-52
- https://doi.org/10.1016/s0885-3924(99)00020-2
Abstract
No abstract availableKeywords
This publication has 12 references indexed in Scilit:
- An update on the clinical use of methadone for cancer painPain, 1997
- Guidance for clinicians in discerning and comparing the price of pharmaceutical agentsJournal of Pain and Symptom Management, 1994
- Methadone in pain uncontrolled by morphineThe Lancet, 1993
- Clinical efficacy of methadone in patients refractory to other μ-opioid receptor agonist analgesics for management of terminal cancer pain. Case presentations and discussion of incomplete cross-tolerance among opioid agonist analgesicsCancer, 1993
- Comment on Bruera et al., Local toxicity with subcutaneous methadone. Experience of two centersPain, 1992
- Individual variability in the response to different opioids: report of five casesPain, 1992
- Local toxicity with subcutaneous methadone. Experience of two centersPain, 1991
- Hypodermoclysis for the administration of fluids and narcotic analgesics in patients with advanced cancerJournal of Pain and Symptom Management, 1990
- Subcutaneous infusions for control of cancer symptomsJournal of Pain and Symptom Management, 1990
- Focal subdermal toxicity with subcutaneous opioid infusion in patients with cancer painJournal of Pain and Symptom Management, 1989